Novonix Limited (NVX) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
分析师预估 每股收益(EPS)为 $-0.40 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.60 vs 预期 $-0.40 (不及预期 -50.5%). 2025: 实际 $-0.52 vs 预期 $-0.35 (不及预期 -48.6%). 分析师准确度: 67%.
EPS 预测 — NVX
67%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$0.60
vs Est –$0.40
▼ 33.6% off
2025
Actual –$0.52
vs Est –$0.35
▼ 32.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — NVX
76%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.006B
vs Est $0.008B
▼ 42.0% off
2025
Actual $0.006B
vs Est $0.006B
▼ 5.7% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
